Acurx Pharmaceuticals, Inc.

NasdaqCM:ACXP Stock Report

Market Cap: US$8.5m

Acurx Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:ACXP Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Jan 25BuyUS$50,000David LuciIndividual49,261US$1.02
06 Jan 25BuyUS$25,000Carl SailerIndividual24,631US$1.02
06 Jan 25BuyUS$10,000Jack DeanIndividual9,852US$1.02
06 Jan 25BuyUS$50,000Robert DeLucciaIndividual49,261US$1.02
06 Jan 25BuyUS$10,000James DonohueIndividual9,852US$1.02
06 Jan 25BuyUS$25,000Joseph ScodariIndividual24,631US$1.02

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ACXP?
Owner TypeNumber of SharesOwnership Percentage
Hedge Funds2,044,5469.28%
Individual Insiders2,572,11211.7%
Institutions2,622,73811.9%
General Public14,803,11567.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 39.1%.

Top Shareholders

Top 25 shareholders own 32.75% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.28%
Sabby Management, LLC
2,044,546US$791.2k0%2.68%
5.21%
David Luci
1,147,541US$444.1k4.49%no data
4.6%
Robert DeLuccia
1,014,043US$392.4k5.11%no data
3.28%
Armistice Capital LLC
723,104US$279.8k0%0.01%
2.4%
The Vanguard Group, Inc.
529,349US$204.9k0%no data
1.66%
Prospect Financial Services LLC
366,576US$141.9k11.4%0.07%
1.36%
3i Fund
299,284US$115.8k0%3.24%
0.86%
Robert Shawah
189,200US$73.2k0%no data
0.78%
Geode Capital Management, LLC
171,487US$66.4k17.1%no data
0.65%
Carl Sailer
142,183US$55.0k21%no data
0.51%
Orca Capital GmbH, Asset Management Arm
113,401US$43.9k0%1.19%
0.48%
Morgan Stanley, Investment Banking and Brokerage Investments
106,201US$41.1k0%no data
0.31%
Vanguard Capital Wealth Advisors, LLC
67,500US$26.1k0%0.03%
0.2%
State Street Global Advisors, Inc.
43,466US$16.8k0%no data
0.16%
BlackRock, Inc.
34,245US$13.3k32.2%no data
0.14%
Hudson Bay Capital Management LP
30,114US$11.7k0%no data
0.14%
NBC Securities, Inc., Asset Management Arm
30,000US$11.6k158,000%no data
0.13%
Joseph Scodari
27,708US$10.7k800%no data
0.12%
Jack Dean
27,546US$10.7k55.7%no data
0.12%
Northern Trust Global Investments
27,286US$10.6k0%no data
0.12%
Renaissance Technologies LLC
26,600US$10.3k81.3%no data
0.1%
James Donohue
22,352US$8.6k78.8%no data
0.068%
Cambridge Investment Research Advisors, Inc.
15,000US$5.8k-15.5%no data
0.045%
Quartz Partners, LLC
10,000US$3.9k0%no data
0.043%
Osaic Wealth, Inc. , Asset Management Arm
9,582US$3.7k-27.7%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/19 15:17
End of Day Share Price 2025/05/19 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Acurx Pharmaceuticals, Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Antonio ArceH.C. Wainwright & Co.
null nullIndependent Investment Research (Aust.) Pty Ltd